Marijuana Stocks

foothilltraded

Due to the current legal status of marijuana, and the relative young age of the industry, only a few marijuana companies are traded on the NASDAQ at present. As the industry grows, more marijuana companies are transitioning from OTC trading to reputable US stock exchanges.

 

AbbVie Inc (NASDAQ: ABBV)

A global, research-based biopharmaceutical company. It has many products including an FDA-approved cannabis-based drug, Marinol. The drug is designed to alleviate nausea in chemotherapy patients and appetite loss in AIDS patients.

 

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)

A biotech company which contributes to the manufacture of medical marijuana products. The primary focus of this firm’s cannabis biotech initiatives is R&D. Based in San Diego, California.

 

Atlantic Alliance Partnership Corp. (NASDAQ: AAPC)

This is a blank check company. It is currently in a merger agreement with Kalyx Development Inc: a leading real estate investment trust in the United States’ regulated cannabis industry.

 

Aurora Cannabis Inc (NASDAQ: ACB)

A producer and distributor of medical cannabis products such as dried cannabis, cannabis oil, CanniMed vegan capsules, and hemp products. Also operates a network of cannabis counseling and outreach centers called CanvasRX.

 

Axim Biotechnologies Inc (NASDAQ: AXIM)

This biotech company researches, develops, produces, and sells pharmaceuticals, nutraceuticals, and cosmetics. It owns several proprietary technologies that aid it in extraction and purification of cannabinoids. Formerly known as Axim International Inc., it is headquartered in New York, New York.

 

Cannabis Science, Inc. (NASDAQ: CBIS)

This company and its subsidiaries develops, produces, and commercializes phytocannabinoid-based pharmaceuticals for US markets. It focuses on medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses. Headquartered in Irvine, California and previously known as Gulf Onshore, Inc.

 

Cannabix Technologies Inc (NASDAQ: BLOZF)

A technology company, Cannabix Technologies develops marijuana breathalyzers for law enforcement and the workplace. It is based in Burnaby, Canada. Formerly known as West Point Resources, Inc.

 

CannTrust Holdings Inc. (NASDAQ: CTST)

A producer and distributor of medical and recreational cannabis in Canada. CannTrust Holdings sells dried cannabis and cannabis extracts to medical patients. Headquartered in Vaughan, Canada. 

 

Canopy Growth Corporation (NASDAQ: CGC)

 

Headquartered in Smiths Falls, Ontario, Canopy Growth Corp and its subsidiaries produce, distribute, and sell cannabis in Canada. It offers dried flowers, oils, concentrates, softgel capsules, and hemps. Formerly known as Tweed Marijuana Inc.

foothilltraded2

Cara Therapeutics Inc. (NASDAQ: CARA)

A clinical-stage biotech company. Cara Therapeutics focuses on development and commercializing new products for pain and itching. Currently its range of products target opioid receptors, but the company is researching cannabinoids to treat neuropathic pain.

 

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP)

A cannabis biotech company. Its research, development, and manufacturing focus on cannabis drugs that can treat chronic, inflammatory, and fibrotic diseases, among others.

 

Cronos Group Inc. (NASDAQ: CRON)

A Canadian cannabis company. It owns and seeks out cannabis-related subsidiaries and licensed producers. Cronos Group was formerly known as Pharmacan Capital Corp. Invests in companies either licensed or actively seeking a license to produce medical marijuana. Headquartered in Toronto, Canada.

 

General Cannabis Corp (NASDAQ: CANN)

This company, headquartered in Denver, Colorado, provides products and services to the regulated marijuana industry and non-cannabis customers in the US. General Cannabis was formerly known as Advanced Cannabis Solutions, Inc.

 

GreenGro Technologies, Inc (NASDAQ: GRNH)

A designer, manufacturer, and marketer of eco-friendly vertical cultivation systems in the US. Formerly known as Authoriszor, Inc, it is based in Anaheim, California.

 

GW Pharmaceuticals Plc. (NASDAQ: GWPH)

This company is building a portfolio of cannabinoid medicines. It already owns Sativex, for multiple sclerosis and cancer pain. It also owns Epidiolex, used in the treatment of childhood epilepsy. It is thought to be developing cannabinoid products for autism spectrum disorders, schizophrenia, and glioma.

 

Harvest Health & Recreation Inc. (NASDAQ: HRVSF)
This company cultivates, processes, and retails cannabis in the United States. It is headquartered in Tempe, Arizona.

HEXO Corp. (NASDAQ: HEXO)

This company’s subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. It has several lines under the HEXO and Hydropothecary brand names. Formerly known as The Hydropothecary Corporation. Headquartered in Gatineau, Canada.

 

Intec Pharma Ltd. (NASDAQ: NTEC)

A clinical-stage biopharmaceutical company. Intec Pharma is using its proprietary Accordion Pill tech to develop drugs, including cannabinoid drugs for lower back pain and fibromyalgia.

 

Kaya Holdings, Inc. (NASDAQ: KAYS)

This company’s subsidiaries engage in legal recreational and medical marijuana in the United States. They grow, cultivate, harvest, and manufacture medical marijuana, and operate retail outlets for recreational and medical cannabis. Headquartered in Fort Lauderdale, Florida, and formerly known as Alternative Fuels America, Inc.).

 

KushCo Holdings, Inc (NASDAQ: KSHB)

Formerly Kush Bottles, Inc., this company distributes packaging supplies wholesale, including many for medical and recreational cannabis dispensaries. It also operates a creative design agency for cannabis and non-cannabis clients. Headquartered in Garden Grove, California.

 

Marrone Bio Innovations, Inc. (NASDAQ: MBII)

This company develops and distributes green bio-based pest management and plant health products. Three of its active ingredients are legal for use on cannabis crops in California’s cultivation market.

 

Medical Marijuana, Inc. (NASDAQ: MJNA)

 

Formerly known as Hemp Deposit Distribution Corp., headquartered in Poway California. Medical Marijuana, Inc. is an operator in medical marijuana and industrial hemp markets, licensing proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It also offers consulting and securities services to businesses and individuals in the legal cannabis industry.

foothilltraded3

New Age Beverages Corp (NASDAQ: NBEV)

A manufacturer of beverages which use yerba mate, green tea, kombucha, and products of this kind. New Age has begun using cannabidiol (CBD) infusions in its expanded range of offerings.

 

PotNetwork Holdings, Inc. (NASDAQ: POTN)

This company’s subsidiaries develop and sell hemp-derived CBD oil products. It also distributes herbal grinders and publishes a hard copy magazine called PotNetwork. Located in Fort Lauderdale, Florida.

 

Psychemedics Corporation (NASDAQ: PMD)

This company works in enforcement. It supports drug testing for employers, law enforcement agencies, school administrators, and parents through hair samples. It offers screening and confirmation for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines.

 

Terra Tech Corp. (NASDAQ: TRTC)

A vertically integrated, cannabis-focused agriculture company. Produces hydroponic herbs and operates medical marijuana retail and adult use dispensaries. Offers a selection of products such as flowers, concentrates, and edibles. Headquartered in Irvine, California.

 

The Green Organic Dutchman Holdings Ltd. (NASDAQ: TGODF)

This company’s subsidiary, The Green Organic Dutchman Ltd., is a cannabinoid research and development company headquartered in Mississauga, Canada. It produces and retails organic cannabis products such as dried and fresh cannabis, cannabis oils, edibles, and seeds for medical applications.

 

Therapix Biosciences Ltd. (NASDAQ: TRPX)

A specialty clinical-stage pharmaceutical company. It focuses on the development of cannabinoid-based drugs. Its current concerns are products intended to treat Tourette’s syndrome, and mild cognitive impairment.

 

Tilray Inc. (NASDAQ: TLRY)

The first marijuana-related company to have an IPO in the United States. It focuses on medical cannabis products, researching, processing, and distributing it to patients, physicians, pharmacies, governments, and hospitals. Operates internationally on 5 continents. Headquartered in Nanaimo, Canada.

 

Village Farms International (NASDAQ: VFF)

This company has a long history in greenhouse produce production. Recently it has shifted some of its focus to cannabis production. Was previously known as Village Farms Canada Inc. Is based in Delta, Canada.

 

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE)

This company focuses on the development of synthetic cannabinoid treatments for transdermal delivery. They are working on two drugs for epilepsy, osteoarthritis, fibromyalgia, peripheral neuropathic pain, and Fragile X syndrome.

 

The Fund’s top ten holdings can be obtained through this link. https://cannabisold.wpengine.com/wp-content/uploads/pdf/CGF-Fact-Sheet.pdf

Cannabis Stocks

If you have an interest in cannabis stock investment, you have several options. Our cannabis mutual fund is one of the first open-end mutual funds to invest primarily in companies related to the cannabis industry. The Fund is diversified across various subsectors of the industry to provide broad-based exposure and help investors capitalize on the fast-growing, innovative cannabis industry. To learn more about investing in cannabis, visit our How to Invest page, or contact us at 800.446.1179/info@cannabisgrowthfunds.com.

foothilltraded4

OF SPECIAL NOTE

Statements, estimates and forecasts are subject to significant legal, business, economic, and competitive uncertainties, including competition, limited access to bank services, litigation, enforcement actions, and the receipt of government authorizations. This includes differences in, among other things, laws, regulations and guidelines relating to the manufacture, transportation, and storage of cannabis, and the conduct of operations, which vary among the U.S. federal government, various states, and foreign jurisdictions. There can no assurance that such estimates and/or forecasts will be realized, and these are not indicative of future investment performance. Historical data is not indicative of future performance.

Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus, a copy of which may be obtained from 888.885.0588. Please read the prospectus carefully before you invest.

Investing involves risk, including possible loss of principal. The cannabis industry is subject to rapidly evolving laws, rules and regulations, and increasing competition which may cause such companies to change business model, shrink or suddenly close. These may limit access to banks, and create significant burdens on company resources due to litigation, enforcement actions, receipt of necessary permits and authorizations to engage in medical cannabis research or to otherwise cultivate, possess or distribute cannabis. Possession and use of cannabis is illegal under federal and certain states’ laws, which may negatively impact the value of Fund investments. Where legalized by states, cannabis possession and use remains a violation of federal law. The companies in which the Fund invests are subject to various laws and regulations relating to the manufacture, management, transportation, storage and disposal of cannabis, including health and safety, conduct of operations, and environmental protection. Even if a company’s operations are permitted under current law, they may not be permitted in the future, and a company may not be able to continue operations in its current location. Controlled substance legislation differs significantly between countries and may limit a company’s ability to sell products. Foreign investing involves social and political instability, market illiquidity, exchange-rate fluctuation, high volatility and limited regulation risks. Emerging markets involve different and greater risks, as they are smaller, less liquid and more volatile than more developed countries. Investments made in small, mid-capitalization and micro-capitalization companies may be more volatile and less liquid due to limited resources or product lines and more sensitive to economic factors. Fund investments will be concentrated in an industry or group of industries, and the value of Fund shares may rise and fall more than more diversified funds. Purchasing and writing put and call options entails greater than ordinary investment risks. Options ownership involves the payment of premiums, which may negatively impact Fund performance. Please see the prospectus for details of these and other risks. Distributed by IMST Distributors, LLC.